Drug detection in oral fluid specimens was used for the first time in the late 1970s, for the pur� pose of therapeutic drug monitoring [1] . Since then, oral fluid ana lysis has increased enor� mously, as can be seen by the increase in the number of publications on this matter over the past few years. This coincided with the develop� ment of more sensitive and reliable analytical equipment. �owever, these advances in tech� �owever, these advances in tech� nological resources were not solely responsible for this situation, as will be discussed further. Indeed, the unique properties of oral fluid and its advantages over other biological matrices played a very important role.
Advantages of oral fluid testing include the fact that the sample is collected noninvasively under direct supervision and without loss of privacy, reducing the risk of an invalid speci� men being provided or sample adulteration and/ or substitution [2] . Furthermore, it is thought that saliva drug concentrations can be related to free drug concentrations in plasma and, consequently, to the pharmacological effects of drugs [3] .
On the other hand, drugs that are ingested orally, as well as those that can be smoked, may be detected in high concentrations in oral fluid following recent use, due to residual amounts of drug remaining in the oral cavity [4] [5] [6] [7] [8] . Therefore, results for these substances may not be accurate because the drug concentration found in the oral fluid may not reflect the blood drug concentration.
Another important disadvantage of study� ing oral fluid is that examinees are sometimes unable to produce sufficient amounts of material for ana lysis [2] .
For a better understanding of the increas� ing importance of this biological specimen on bioana lysis, as well as the need for sensitive techniques, this review will briefly discuss oral fluid physiology and the underlying mecha� nisms of drug incorporation. In addition, col�
In addition, col� In addition, col� lection devices, detected substances and fields of application will be reviewed. Finally, the avail� able analytical techniques for drug detection in oral fluid will be outlined, since their application represents the main goal of this paper.
Physiology & mechanisms of drug incorporation
The terms oral fluid and saliva are often used in an interchangeable manner to designate the same biological specimen. �owever, oral fluid is the liquid sample obtained from the oral cavity, and constitutes a number of secretions from several Current technologies and considerations for drug bioanalysis in oral fluid Drug oral fluid ana lysis was first used almost 30 years ago for the purpose of therapeutic drug monitoring. Since then, oral fluid bioana lysis has become more popular, mainly in the fields of pharmacokinetics, workplace drug testing, criminal justice, driving under the influence testing and therapeutic drug monitoring. In fact, oral fluid can provide a readily available and noninvasive medium, without any privacy loss by the examinee, which occurs, for instance, during the collection of urine samples. It is believed that drug concentrations in oral fluid may parallel those measured in blood. This feature makes oral fluid an alternative analytical specimen to blood, which assumes particular importance in roadside testing, the most published application of this sample. Great improvements in the development of accurate and reliable methods for sample collection, in situ detection devices (on-site drug detection kits), and highly sensitive and specific analytical methods for oral fluid testing of drugs have been observed in the last few years. However, without mass spectrometry-based analytical methods, such as liquid chromatography coupled to mass spectrometry (LC-MS) or tandem mass spectrometry (LC-MS/MS), the desired sensitivity would not be met, due to the low amounts of sample usually available for ana lysis. This review will discuss a series of published papers on the applicability of oral fluid in the field of analytical, clinical and forensic toxicology, with a special focus on its advantages and drawbacks over the normally used biological specimens and the main technological advances over the last decade, which have made oral fluid ana lysis of drugs possible.
future science group sources [8] , including saliva. In fact, three pairs of major salivary glands (parotid, submaxillary and sublingual), as well as an estimated 450-750 minor accessory salivary glands (situated on the tongue, the buccal mucosae and the palate) and oro�naso�pharyngeal secretions, contribute to some extent to its production. Therefore, oral fluid is generally accepted as a more accurate definition of this mixture of fluids [9] .
Oral fluid contains the same electrolytes that are present in other body fluids, includ� ing water (99%) and mineral salts. Proteins (mucins) and some enzymes for digestion are also present, but at very low levels. This sample is hypotonic compared with serum, although its ionic concentrations are not constant due to the circadian rhythm.
The p� of oral fluid is approximately 6.8, but it can be higher in the case of an increase in the salivary flow. In this situation, its p� can even be greater than that of plasma [10] .
An adult can produce as much as 1000 ml oral fluid per day, and typical flows are approxi� are approxi� mately 0.05 ml/min while sleeping, 0.5 ml/min while spitting and up to 3 ml/min while chewing gum [11] . This flow rate may be influenced by several factors, including the individual's emo� tional state, pregnancy or menopausal�related hormonal changes, or by the use of drugs [9] .
One common feature when collecting oral fluid samples is the so�called 'dry mouth syn� drome'. This can be due not only to the anxiety provoked by the collection procedure, but also to a lack of proper hydration by the examinee [12] . Furthermore, the use of anti�adrenergic and anticholinergic drugs, or even of illicit drugs such as opiates, amphetamines and cannabis [9] , may also contribute to this syndrome.
Different mechanisms for drug incorporation are thought to occur: passive diffusion through the membrane, active processes against a concen� tration gradient, filtration through pores in the membrane and pinocytosis [3, 13] . Nevertheless, most drugs appear to be incorporated by a simple passive diffusion process that depends on their physicochemical properties (e.g., pKa and molecular weight), the degree of binding to plasma proteins and the p� of both blood and oral fluid [9, 14] .
Therefore, nonionized lipophilic drugs can easily cross the barrier between plasma and saliva, and their concentration in the latter is dependent on the nonprotein�bound plasma concentration. The low concentrations of diazepam and other benzodiazepines usually seen in this specimen represent a valid example of this dependence, since these compounds are highly protein bound [15, 16] .
Drugs that are basic in nature, such as amphetamines, cocaine and opiates, gener� ally have higher concentrations in oral fluid than in blood, whereas acidic drugs have much lower concentrations. The concentrations of D 9 �tetrahydrocannabinol (T�C) in this specimen are more variable in oral fluid than in blood [4] , possibly due to the deposition of T�C in the oral cavity. Furthermore, current belief is that the majority of T�C found in oral fluid originates from this depot of active T�C [6] , since little T�C is secreted into saliva [17] . �owever, this effect is also seen for other drugs, such as nicotine after tobacco smoking and buprenorphine after sublingual administration [12] .
The p� of oral fluid plays an important role in the case of weakly basic drugs, and can greatly affect their salivary concentrations. Indeed, those drugs whose pKa is close to the saliva's p� will have their degree of ionization dramat� ically altered with p� changes, and this will be reflected in their saliva�to�plasma ratio [10] . This influence of the salivary p� on the saliva� to�plasma ratio of several drugs is perhaps the reason why ratios determined experimentally differ from theoretical values calculated from the �enderson-�asselbach equation [3, 18] .
On the other hand, with an increase in the flow rate, the composition of the specimen will change, including its p�, and therefore the circumstances of the collection can affect the production of oral fluid, which in turn will also change the drug content [8] . For this reason, the protocol for saliva collection can differ depending on the study (with or without stimulation) and may be highly important for the determination of saliva�to�plasma ratios [10] .
�owever, care should be taken in the estab� lishment of these ratios, since significant intra� and inter�individual differences exist, which have been discussed elsewhere [19] [20] [21] [22] [23] [24] [25] . Nevertheless, these differences are not so large in the case of alcohol and antiepileptic drugs [22, 25] .
The research concerning oral fluid ana lysis in the case of alcohol consumption has been reviewed by Drummer [12] , and the oral fluid�to�plasma concentration of this drug is similar to that pre� dicted based on the water content of the two fluids, and has been used to assess alcohol exposure.
One important feature regarding oral fluid ana lysis is that, contrary to what hap� pens when other biological specimens such as future science group blood or urine are analyzed, the parent drug is the main compound detected, rather than its metabolites.
It should be noted, however, that there is the possibility of passive contamination in this type of ana lysis. This can occur mainly at two levels: by exposure to an environment where drugs are being consumed by others (e.g., expo� sure to cannabis smoke) [26] and by contami� nation from drugs taken orally, meaning that the detected drugs may not proceed from the bloodstream. Therefore, this possibility should be taken into account in the interpretation of the obtained results.
Collection procedures & devices
There are two major advantages of oral fluid test� ing. First, as discussed above, drug concentrations in this specimen can be related to plasma free drug concentrations and, consequently, to the pharmacological effects of drugs. Second, saliva collection is made in a noninvasive and simple manner (under close observation, if necessary), without infringing on the examinee's privacy. This latter characteristic makes on�site specimen collection easy to perform, which is advantageous in the assessment of drug�impaired driving situ� ations. Furthermore, the collection of this speci� men is less liable to adulteration or substitution in comparison with urine sampling [27] [28] [29] .
A variety of methods are available for oral fluid collection, with or without stimulation, and these include spiting, draining, suction and collection on various types of absorbent mate� rial. �owever, care should be taken since the concentration of the drugs can be affected by the collection procedure used.
Several techniques may be used to collect stim� ulated saliva, the simplest of which involves move� ments of the tongue, cheek or lip, without any external stimulus [30, 31] . On the other hand, this stimulation can be made mechanically by chew� ing a variety of materials, such as paraffin wax, Parafilm ® , teflon, rubber bands or gum base [13, 32] . Likewise, a lemon juice drop or citric acid can be placed in the mouth to provide a gustatory stimu� lus for saliva production [11, 30, 32, 33] . Following this stimulation, saliva can then be spat, suctioned, absorbed or swabbed for collection [33] .
This production stimulation may present several problems capable of compromising the accuracy of the test, however. For instance, there are some drugs and/or metabolites that can be absorbed by Parafilm, and paraffin contains compounds that may affect chromatographic ana lysis [34] . Furthermore, it is possible that the salivary composition is changed by the stimula� tion process, thereby potentially affecting drug concentrations in oral fluid [13, 35] . In addition, citric acid changes saliva p�, which may alter drug concentrations in this specimen, and has also been shown to alter immunoassay drug test results [30, 32] . In fact, acidic stimulation has been shown to lower codeine [29, 36] , methamphetamine [37] and cocaine [38] concentrations in oral fluid.
Nonstimulated saliva can be collected by the draining method, which is performed by allow� ing saliva to drip from the mouth into a col� lection container [33] , or can be easily obtained by spitting, providing a neat sample. �owever, this is relatively viscous and less easily pipetted than, for instance, urine, and its collection can pose potential occupational health and safety problems. In addition, and because it may also be contaminated with food, it may not provide a fluid of uniform concentration.
Therefore, the sample is typically collected using an absorbent pad/foam, which is subsequently squeezed or mixed into a diluent (usually buffer) to extract the oral fluid and provide a less�viscous and easier�to�analyze specimen. Some devices have a volume indicator, showing if sufficient oral fluid has already been collected [29, 36] .
�owever, the collected sample volume will often be less than 1 ml and, therefore, sophis� ticated and sensitive detection techniques are mandatory to achieve the desired sensitivity, as will be further discussed.
The advantages and drawbacks of sev� eral collection devices have been extensively reviewed [39, 40] .
One of the problems that used to be associated with these collection devices was that the actual volume of sample was not accurately known. This has been overcome by the use of a volume ade� quacy indicator in the collection pad. This makes the collected volume well known, improving the accuracy of the measurements in this specimen. Indeed, for example, the Quantisal™ device's indicator turns blue when a sample volume of 1 ml (±10%) is collected [201] .
Variable collection and recovery volumes between different devices may cause quantita� tive differences if it is assumed that:
n A consistent volume is collected n A consistent volume is recovered from the device n A consistent amount of drug is recovered from the device future science group This latter issue is important, since it is well known that analyte recovery from the collec� tion device is concentration dependent and this assumes particular relevance at low concentra� tions. For this reason, the evaluation of each device's performance in terms of analyte recov� ery should be targeted at a screening assay cut�off or a relevant physiological concentration.
Another approach to overcome the variability of collected volumes may be the weighing of the collection devices before and after sample collection [41] .
A variety of devices for oral fluid testing are commercially available, such as Omni� Sal ® (Cozart Biosciences Ltd, Abingdon, UK), Salivette ® (Sarstedt AG, Rommelsdorf, Germany), Intercept ® (OraSure Technologies, Bethlehem, PA, USA) and Quantisal™ (Immunalysis Corporation, Pomona, CA, USA). These devices usually consist of a sor� bent material that becomes saturated in the mouth of the donor, and the oral fluid is recov� ered by centrifugation or by applying pressure [42, 43] . The device is often placed in a container that contains a stabilizing buffer solution [44] . These buffer solutions are not the same for all the devices that use this type of approach, and this is why these devices show differences in their performance, for example concerning drug recovery. The acceptability of sample collection devices is determined both by the speed of collection and ease of handling, and the referred devices all have their advantages and drawbacks. In addition, attention should be paid to the devices' performance, as some collectors have been shown to absorb drug(s) irreversibly, meaning that the drugs are not able to leach out into the postcollection buffer, impairing the accuracy of quantitative ana lysis. Several studies have been made on this issue, and it appears that drugs are not affected to the same extent. Some studies have even obtained contradictory results.
Indeed, in one study, a recovery of codeine from the Salivette device of more than 80% was reported [36, 45] ; while, in another study, lower recoveries (39-42%) were found [29, 39] . On the other hand, only approximately 38% of T�C is recovered from the Intercept device, whereas recoveries of 3,4�methylenedioxymethamphet� amine (MDMA), cocaine, morphine, codeine, diazepam and alprazolam from the same device are much higher [39] . Moreover, the Cozart ® col� lector shows good recovery for T�C [36, 46, 47] and methamphetamine [37, 48] .
Significant differences in drug recoveries from the sampling material are reported in the litera� ture, and these will also lead to variations in the measured concentrations in oral fluid.
Several solutions are proposed to overcome this problem. For instance, a modification of the sampling procedure for the Intercept collector, which consisted of the addition of methanol to the elution buffer, resulted in complete recovery of T�C over a large concentration range [41] . Other studies were conducted on the recovery of other drugs from the same device [49, 50] , and significant losses for 7�aminoclonazepam and lysergic acid diethylamide (LSD) were found. Another study, by Quintela et al. [48] , evaluated the in vitro performance of the Quantisal device for amphetamine, methamphetamine, mor� phine, codeine, cocaine, benzoylecgonine (BE), methadone, oxazepam and T�C. In general, recoveries were higher than 90%, but lower for BE (82%).
For T�C, however, high recovery was obtained (81.3-91.4%). Other previous studies, using Salivette, showed that significant amounts of the drugs remained entrapped on the device [51] [52] [53] .
Another important feature that should be taken into account in oral fluid ana lysis is drug stability or, more accurately, drug instability in the matrix, which can affect the utility of the collection process [40] . The inherent chemical instability of drugs may be exacerbated in oral fluid by the collection device and/or buffer. This issue is of utmost importance in oral fluid ana� lysis, together with analyte recovery from the collection device, because drug concentrations are generally low in this specimen and, therefore, the detectability of the drug may be limited [8] . Stability of several analytes, such as T�C, morphine, 6�acetylmorphine (MAM), BE and designer amphetamines, was evaluated in oral fluid samples after collection and was extensively discussed [29, 48, [54] [55] [56] [57] .
The stability of analytes can be affected by a number of conditions, including the use of pre� servatives in the case of flunitrazepam [58] and storage temperature and duration in the case of MAM [59] or T�C [29] .
In conclusion, no type of collection device is clearly superior based on design or ease of use. On the other hand, the recovery studies con� ducted on some devices do suggest that drug desorption may limit the usability of some col� lection materials. Therefore, more information is required for all drugs likely to be measured in oral fluid, and for each collection device.
future science group Applicability of oral fluid ana lysis Oral fluid can be used to assess an individual's exposure to virtually every class of compounds, but drugs of abuse are by far the most detected substances. This is mainly due to the deleterious consequences of these substances' misuse, both in workplace medicine and motor vehicle driv� ing. For this reason, scientific literature is prolific in analytical techniques aimed at detecting and quantitating a variety of classes of abused drugs, namely opiates [52, [60] [61] [62] [63] [64] [65] , cannabinoids [54, [66] [67] [68] [69] [70] [71] , amphetamines [21, 55, [72] [73] [74] [75] [76] [77] , cocaine [78, 79] and benzodiazepines [58, [80] [81] [82] [83] [84] [85] [86] [87] . Other substances such as ketamine, g�hydroxybutyrate (G�B) [88, 89] , antibiotics [90] , analgesics [91, 92] , antitus� sives [93] , cyanides and other tobacco compounds [94] [95] [96] , and sildenafil [97] , have also been ana� have also been ana� lyzed. Oral fluid has additional relevance in the case of opiate testing, since high amounts of 6�monoacetylmorphine can be detected in oral fluid in the case of heroin consumption, as well as detectable amounts of heroin itself, and therefore heroin abuse can be easily detected [12] .
Oral fluid presents a wide field of analytical applications that take advantage of the afore� mentioned advantages [2] concerning, for exam� ple, therapeutic drug monitoring [1, 25, 45, 80, 98, 99] , pharmacokinetic studies [4, 5, 19, 37, 100] , workplace medicine [27, 101, 102] or even detection of illicit drugs in driving situations [47, [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] .
The application of oral fluid ana lysis to assess drug prevalence is definitely desired, and a posi� tive correlation to impairment has already been shown [106, 113] . �owever, it should be pointed out that, for most substances, a measured oral fluid concentration cannot be used to predict the corresponding plasma concentration, due to the intra� and inter�individual differences discussed earlier.
Nevertheless, the assessment of drug�impaired driving is one of the most impacting applications of oral fluid testing, which has contributed to the development of several collection materials for laboratorial ana lysis and collection devices designated for on�site applications.
Analytical technologies
Due to developments in technology, it is possible to detect and quantitate drugs in biological spec� imens at levels that were unreachable a few years ago. As discussed earlier, one of the main disad� vantages of oral fluid is the fact that one must be able to detect very small amounts of drugs, due both to their low concentration in this specimen and to the fact that usually there is little sample available for ana lysis (often less than 1 ml). This latter drawback may be manageable by the use of multianalyte methods, providing the optimiza� tion of sample volume and eventually of con� firmation ana lysis, if necessary. Therefore, the development of this type of method is highly desirable for oral fluid drug testing. For instance, Gunnar et al. have published a method by gas chromatography (GS)-mass spectroscopy (MS) that is capable of determining 30 derivatized drugs in 250 µl of oral fluid [49] . A few LC-MS/ MS multianalyte methods have also been pub� lished, allowing the simultaneous determina� tion of several abused drugs [50, 114, 115] , benzodi� azepines and hypnotics [50, 115] . A method for the simultaneous determination of 49 substances, including some antipsychotics and antidepres� sants, has also been published [116] . Therefore, sensitive and selective techniques are manda� tory to achieve the desired low levels. The main analytical techniques usable for drug detection, including their advantages and drawbacks and the main parameters that can affect the ana� lysis, will now be discussed, in light of existing literature on the matter.
n On-site collection devices The increased use of illegal drugs gave rise to the need for quick and reliable methods, which have been developed and improved since the 1990s [103] , for the fast screening of drugged drivers.
Portable devices have been developed for drug detection in several biological f luids, namely urine, oral fluid and sweat. The perfor� mance of various urine on�site screening tests has been evaluated [117, 118] . �owever, as stated previously, oral fluid concentrations of drugs can be related to their plasma concentrations and, therefore, to the pharmacological state of the individual [119, 120] , while drug detection in urine does not necessarily mean that the indi� vidual was influenced at that specific time [121] . Therefore, and due to the ease of its collection, oral fluid seems to be a better sample for this purpose compared with urine.
One advantage of these portable devices is that they allow the initial testing for drugs to be easily carried out in the field. A preliminary drug test result is usually provided within a few minutes, without the need for sophisticated and/ or expensive laboratory equipment. [2] . On�site collection kits may also provide an indirect aid to traffic control, since the tested individual is more likely to admit drug use after a positive test result. On the other hand, individuals under the influence of drugs may be deterred from driving, since people are starting to become aware that traffic control police are able to perform screening tests for drug use [103] .
�owever, the assessment of these devices' per� formance is not objective, because, for most, the specifications are not consistent [2] and details concerning the detectability conditions are often missing. On the other hand, the ease of use of the devices should also be evaluated, taking into consideration the opinion of traffic regulation officers, since they are the ones who will be using them in the field.
The possibility of supervision of the sampling process is especially important in terms of law enforcement, since sample adulteration is avoided and the possibility of substitution or contamina� tion appears to be minimal. For these reasons, the significance of oral fluid as a primary matrix in roadside testing can hardly be questioned. Indeed, oral fluid testing has revealed its use� fulness in detecting drugs of abuse in various studies using several devices [46, 106, [122] [123] [124] [125] [126] [127] [128] [129] [130] , and it can be seen as a good substitute for whole�blood samples [128] , unless a quantitative ana lysis of blood levels is desired.
The advantages of on�site testing are rapid turnaround times, reduced costs and the fact that the test can be carried out virtually any� where [129] . �owever, this type of technology presents some problems relating to T�C detec� tion, since the removal of the drug from the collection pad is difficult [67, 130] .
The scourge of driving under the influence of drugs or alcohol is responsible for thousands of accidents every year, and up to 25% of them involve drivers who tested positive for drugs [131] . For instance, in a roadside study by Samyn et al., blood ana lysis of drivers suspected of impair� ment revealed the presence of MDMA in 35% of cases; in addition, amphetamine, cocaine and cannabis were detected in many of these [104] .
The deleterious consequences of drug� impaired driving on road safety led the European Commission to promote scientific studies based on oral fluid ana lysis.
The first of these studies was the Roadside Testing Assessment (ROSITA), aimed at assess� esting Assessment (ROSITA), aimed at assess� Assessment (ROSITA), aimed at assess� ssessment (ROSITA), aimed at assess� aimed at assess� at assess� ing the value of on�site tests at the roadside, and also to give recommendations for the use of roadside testing equipment in European coun� tries. Police officers from 16 countries were sur� veyed, and saliva was shown to be the preferred matrix for drug testing. The reasons for such a choice are quite obvious, namely its ready avail� ability, low invasiveness and good correlation with impairment. Test configuration was also evaluated in this survey, and the ideal would be a single�use multianalyte test able to provide a clear and unambiguous test result within a 5�min interval [103, 202] . A collaborative study between the USA and the European Union (ROSITA�2) has been conducted both to assess illegal drug use among motor vehicle operators and to evaluate the effectiveness of on�site oral fluid drug�detection technologies. Within the scope of this study, which was completed in 2005, Crouch et al. have tested the laboratorial performance of ten different devices, namely concerning their ability to meet the manufac� turers' claimed cut�off concentrations for several drug classes, including amphetamines, cocaine and metabolites, opiates and cannabinoids [132] . Two devices were also evaluated for benzodiaz� epines. The devices' results were compared with laboratory�based immunoassay and MS results, both in terms of sensitivity and specificity.
Another study is ongoing in Europe, the Integrated Project Driving under the Influence of Drugs, Alcohol and Medicines (DRUID), which involves more than 20 European coun� tries. The objective of this study is to gain new insights to the real degree of impairment caused by psychoactive drugs and their actual impact on road safety, giving scientific support to the EU transport policy to establish guidelines and measures to combat impaired driving [203] .
A study has been conducted in the US (Pilot Test of New Roadside Survey Methodology for Impaired Driving), aimed at developing and test� ing new procedures for the assessment of impaired driving. In this study, oral fluid samples of over 600 randomly selected drivers were collected and analyzed, and blood was also collected in approximately half of those subjects. Several drug classes were included in this study, including both abused and prescription drugs [204] .
n Immunoassays In recent years, extraordinary advances in ana� lytical techniques have enabled the detection of drugs and metabolites in alternative specimens. The strategy for drug testing in biological flu� ids (e.g., urine, blood and oral fluid) usually future science group begins with screening procedures, which should be able to detect or exclude a drug class and elude false�negative results [3] . This is extremely useful, especially for those laboratories that are required to analyze a large number of samples routinely, saving time and money that would be wasted in more expensive confirmatory methods (usually MS�based techniques), while most of the samples would be negative.
Four interpretations are possible following a drug test:
n True�positive, when the test correctly detects a drug in the analyzed specimen n False�positive, when the test incorrectly detects the presence of a drug where no drug is present n True�negative, if the test correctly confirms the absence of a drug n False�negative, when the test fails to detect a drug that is actually present in the sample A test's sensitivity is determined by its ability to detect the presence of a drug at or above a cut�off level [133] .
For obvious reasons, to choose this cut�off level one must optimize the number of true� positive and true�negative samples, and the number of false�positives and false�negatives should be kept to a minimum. Indeed, if the cut�off is set too low, the number of false� positive samples will be too high and there will be an unnecessary high number of con� firmation analyses, as stated previously. On the other hand, a cut�off value that is too high will lead to a large number of false�negative samples, impairing the test's usefulness in its applications, namely in the clinical and forensic fields [44] . �owever, this is not an easy task, since these tests are designed for maximum sensitivity, in order to minimize the possibility of a false�negative sample, which increases the probability of obtaining a false�positive result.
Another common characteristic of immu� noassays is their specificity or, more accurately, their lack of specificity. This means that these tests are, in general, not able to discriminate between different drugs or metabolites from the same class. On the other hand, there is also the possibility of a false�positive result deriving from the consumption of some over� the�counter medications, which are known to interfere with amphetamine screenings, origi� nating a positive result. Perhaps the term 'pre� Perhaps the term 'pre� sumptive positive' would be more accurate to define this situation, since that sample would be positive, although not for drugs in the con� firmation profile. This phenomenon is known as cross�reactivity, and it also occurs when the test cannot distinguish between chemically similar substances [81, 133] .
Despite these drawbacks, immunoas� say techniques are the most commonly used methods for the screening of illicit drugs in biological specimens, including urine, blood and other matrices such as oral fluid and hair. This is due to the advantages that they pres� ent over other techniques, namely that the sample volume needed to perform the test is small (usually approximately 25 µl), which is extremely important in oral fluid ana lysis, since the amount of sample available is usu� ally limited, and there is no need for sample pretreatment [44] .
A few studies have been published on the use of immunoassays for drug screening in oral fluid, and these concerned the detection of opiates [40, 54, 60, 134] , including methadone and its metabolite 2�ethylidene� 1,5�dimethyl� 3,3�diphenylpyrrolidine (EDDP) [135] , cocaine and metabolites [57, [136] [137] [138] [139] , cannabinoids [40] and amphetamines [40, 140, 141] . Benzodiazepines were also screened using this specimen [40, 81] and, more recently, dextromethorphan [95] was also studied.
Special attention should be paid to the ana� lytical challenge that the screening of highly potent benzodiazepines, such as flunitrazepam, represents in oral fluid ana lysis. Indeed, these compounds are usually present in the low nano� gram range [58, 86] and, therefore, often remain undetected by traditional enzymatic assays. This lack of sensitivity may be overcome by the use of specific immunoassays for these substances or their metabolites. Indeed, studies have been per� formed on this type of assay [142] , although their use in oral fluid ana lysis is not documented.
Immunoassay�based techniques represent highly sensitive and cost�effective technology; however, their lack of specificity makes the confirmation of presumptive�positive samples mandatory. This confirmation ana lysis is usu� ally performed by highly specific MS�based methods, which are designed to identify unequivocally the present drug(s) and elude false�positive results.
The reader is referred to the review by Townsend et al. for a more comprehensive insight on immunoassay techniques, including biosensor technology [143] .
Current technologies & considerations for drug bioanalysis in oral fluid | Review future science group n Gas chromatography-mass spectrometry Both qualitative and quantitative toxicological analyses are required to be reliable, and this applies to all fields of analytical toxicology, including clinical and forensics. The hyphena�
The hyphena� tion of chromatographic techniques to mass spectrometers has brought a significant improve� ment in drug testing in biological specimens. This is of particular importance in the fields of clinical and forensic toxicology, for which the needed specificity and sensitivity could be met [144] .
Gas chromatography-mass spectrometry was the most utilized technique for the confirmation of a number of organic compounds back in the 1990s, mainly due to the availability of spectral libraries for drugs and metabolites [145] .
In addition, GC-MS is a very reproducible technique, and consistent mass spectra can be obtained in different laboratories, providing that the ionization conditions are the same (usually electron ionization at 70 eV). This is the reason why it is still the gold standard in mass detection specificity [146] .
Gas chromatography-mass spectrometry is currently available in most laboratories, and this is still the main technique for confirmation and quantitation of drugs and their metabolites in biological specimens, including the so�called 'alternative' specimens such as oral fluid, hair and sweat.
Analysis by GC-MS generally requires the extraction of the analytes from the matrix and, in most cases, their chemical derivatization in order to improve peak shape and/or allow chromatographic ana lysis. Typical limits of quantitation are in the range of approximately 1-10 ng/ml, and the ability to achieve them obviously depends on the sample volume. This presents a limitation in terms of oral fluid, not only because of the low amounts at which drugs are present in this specimen, but also due to sample availability for ana lysis. For example, typical concentrations of 11�nor�D9�tetra� hydrocannabinol�9�carboxylic acid in oral fluid are in the low picograms per milliliter range [66] . Analysis of these low amounts of drugs in bio� logical matrices are, in general, impaired by the presence of co�extracted endogenous com� pounds, which usually lead to an increase in the background noise, decreasing the analyte's signal�to�noise ratio (S/N). Therefore, and to perform a valid quantification, the S/N must be increased, which can be performed using 2D chromatography. This method is able to augment S/N by the selective transfer of a small segment of GC eluent that contains the ana� lytes of interest to a second column coupled to a mass spectrometer, reducing or eliminating the interference of endogenous substances [67, 147] .
The S/N may also be increased using MS/ MS, which allow LODs of approximately 0.01 ng/ml [66] . This type of technology was developed for the measurement of low�concen� tration analytes in biological samples, including blood and urine. �owever, it is also extremely useful in those situations where sample amount is critical, as frequently occurs when abused drugs and their metabolites are analyzed in alter� native matrices. Of particular interest is its appli� cation to drugs that represent a more challenging analytical assay (e.g., cannabinoids), therefore requiring a MS/MS approach to achieve the required limits of detection.
Another type of GC-MS/MS technology applicable in oral fluid ana lysis is the ion�trap MS. These mass spectrometers create a magnetic field that holds the formed ions until they are sequentially released to the detector. Many of the advantages of an ion�trap derive from being able to monitor ions on demand, which means that they can be accumulated in the trap to improve sensitivity.
When the number of analytes is too big, an approach is to use fast GC methods, which allows a reduction in the time of ana lysis, maintaining acceptable resolution. Fast GC was developed following modifications on the quadrupole mass spectrometers, including reduced column bore size and more efficient capillary columns, rapid heating�rate ovens and high�pressure carrier gas control [147] . Applications include the ability to analyze 30 different drugs in oral fluid [49] .
Several papers have been published on the use of GC-MS/MS for oral fluid ana lysis, including the detection and quantitation of several drug classes in this specimen. For a better understand� ing, most of the papers published over the last decade are summarized in Table 1 [148] [149] [150] [151] [152] [153] [154] [155] [156] .
n Liquid chromatographymass spectrometry Recent years have seen the development of pow� erful technologies that have provided forensic scientists with new analytical capabilities that were unthinkable only a few years ago [157] . The most spectacular analytical improvement was the advent of LC-MS, for which there has been an explosion in the range of new products available for solving many analytical problems,
lC-Ms
This is a highly sensitive analytical technique, allowing the detection of extremely low amounts of drugs in biological specimens future science group 
GC-EI-MS 10 ng/ml [62] COC, BE, EME, AEME GC-EI-MS 2 ng/ml; 2 ng/ml for MOR and COD; 2 ng/ml; 3 ng/ml for MAM, hydromorphone and oxycodone; 3 ng/ml; 10 ng/ml for hydrocodone [64] COC and BE Stimulation citric acid GC-EI-MS 1 ng/ml; 8 ng/ml [78] COD, norcodeine, MOR and normorphine GC-EI-MS 2.5 ng/ml; 2.5 ng/ml for all analytes [20] MOR, COD, dihydrocodeine, diacetylmorphine and MAM 0.025-0.5 ml Cozart ® Rapiscan SPE (Bond Elut Certify) BSTFA + 1% TMCS DB-5MS EIA, GC-EI-MS 5 ng/ml; 5 ng/ml for all compounds [60] COC, AEME, EME and COET 0.5 ml Salivette Automated SPE (HCX Isolute columns)
DB-5MS GC-PCI-MS/MS 0.1 ng/ml for COC and 0.5 ng/ml for AEME, EME and COET; 2 ng/ml for COET and COC, and at 5 ng/ml for EME [148] COD, MOR and MAM GC-PCI-MS 0.7 ng/ml; 2.3 ng/ml for COD, 2.0 ng/ml; 6.7 ng/ml for MOR, 0.6 ng/ml; 2 ng/ml for MAM [52] ELISA and GC-EI-MS 1 ng/ml; 1 ng/ml for THC; 2 pg/ml for THC-COOH [67] MEK, IPA, DMF, ACE and NMF 1 ml Spitting HS-SPME DB-WAX GC-EI-MS 4, 3, 6, 50 and 100 ng/ml for ACE, MEK, IPA, DMF and NMF, respectively; 160 ng/ml for ACE, MEK and IPA and 300 ng/ml for DMF and NMF [151] 11-nor-9-carboxytetrahydrocannabinol 0.1 ml Intercept SPE (CEREX ® Polychrome) HFIP and PFAA DB-5 GC-NCI-MS/MS 0.01 ng/ml; 0.01 ng/ml [66] 2-carboxytetrahydrocannabinol, THC, GC-EI-MS 2.5 ng/ml; 5 ng/ml for AP, MDA, MDMA and MDEA; 1 ng/ml; 5 ng/ml for MA; 5 ng/ml; 25 ng/ml for HMA; 2.5 ng/ml; 25 ng/ml HMMA [72] MA and AP Stimulation citric acid and Salivette GC-EI-MS 50 ng/ml; 2.5 ng/ml for MA; 2.5 ng/ml for AP [21] MDMA, MDA, MDEA, AP and GC-EI-MS 2 ng/ml; 5 ng/ml for AP; 1 ng/ml; 2 ng/ml for MA; 5 ng/ml; 5 ng/ml for MDA; 1 ng/ml; 5 ng/ml for MDMA; 2 ng/ml; 5 ng/ml for MDEA; and 1 ng/ml; 5 ng/ml for MBDB [74] 
GC-EI-MS
0.3-6.9 ng/ml; 0.9-20.9 ng/ml [153] 15 psychoactive amines 0.1 ml Spitting HFBA
DB-5MS
GC-EI-MS 5 ng/ml for all compounds except 10 ng/ml for PSEPH, NEPH and EPH; 20 ng/ml for all compounds [154] AP and AM GC-EI-MS 10 ng/ml; 2.5 ng/ml [37] MDMA, MDA and HMMA ELISA; GC-EI-MS 25 ng/ml for oxycodone and 50 ng/ml for meperidine and tramadol with ELISA; 10 ng/ml for all compounds with GC-EI-MS [92] Dextromethorphan, dextrorphan 1 ml Quantisal SPE (Clin II) BSTFA + 1% TMCS
ELISA; GC-EI-MS 1 ng/ml; 10 ng/ml [95] 30 drugs of abuse 
DB-35MS
Fast GC/EI-MS [49] Nicotine and cotinine 
DB-1MS
GC-EI-MS 0.60 ng/ml; 0.011 µg/ml for nicotine and cotinine [94] Nicotine, cotinine, norcotinine and trans-3-hydroxycotinine 0.5 ml Salivette SPE (Clean Screen) BSTFA + 1% TMCS HP-5 GC-EI-MS 5 ng/ml; 5 ng/ml [95] Cyanide and thiocyanate 0.5 ml Spitting LLE (ethyl acetate) Pentafluorobenzyl bromide 5% phenyl polysiloxane GC-EI-MS 26 ng/ml for cyanide; 290 ng/ml for thiocyanate [96] Modafinil, selegiline, crotetamide, cropropamide, pentetrazol, EPH, NEPH, sibutramine, COC, BE, EME, AP, MA, COD and dihydrocodeine GC-EI-MS 0.3-2.5 ng/ml; 0.8-11.4 ng/ml [116] Levetiracetam 1 ml
Omni-Sal SPE (Bond Elut Certify) MSTFA + 2% TMCS HP-5MS GC-EI-MS 10 ng/ml; 2200 ng/ml [22] [158] . �owever, assessing which of these ionization techniques is more suitable for developing a new procedure must be made on a case�by�case basis. For example, APCI is more appropriate for unionized analytes, and the sensitivity depends on the analyte structure and apparatus [144] . On the other hand, ESI interfaces permit MS analy� ses of molecules in the molecular weight range of drugs of abuse (50-600 Da) or larger molecules, including proteins as large as 232 kDa [147] ; this is the most used ionization technique.
Related to LC-MS, tandem mass spectrom� etry (LC-MS/MS) offers superior sensitivity and specificity, especially if compared with the use of a single quadrupole. These instruments, when operated in the multiple reaction moni� toring mode (MRM), allow the detection of extremely low levels of analytes in complex bio� logical samples, reducing sample pretreatment and ana lysis time.
One limitation of LC-MS/MS, mainly in ESI mode, is its susceptibility to matrix effects, causing unwanted ion suppression or enhance� ment [159] [160] [161] [162] . For example, Dams et al. found that ESI and APCI showed matrix effects, with ESI being much more susceptible than APCI [161] . Indeed, the common and early per� ception that utilization of LC-MS/MS practi� LC-MS/MS practi� LC-MS/MS practi� cally guarantees selectivity is being challenged by a number of reported examples of lack of selectivity due to ion suppression or enhance� ment phenomena caused by the sample matrix and interferences from metabolites, as well as 'cross�talk' effects.
These effects are capable of affecting ion ratios in the mass spectrum, potentially impairing the assay's accuracy. Several strategies can be used to evaluate and overcome this problem, and these have been reviewed by Matuszewski et al. [163] .
Ion�suppression effects may occur to a greater extent with increased solvent amount in the chamber. This problem can be addressed via the reduction of the amount of mobile phase exit� ing the column by means of nano�LC systems, which will be further discussed below. Another possible approach is to reduce matrix constitu� ents by reducing sample volume or adjusting mobile�phase composition in order to reduce co� elution of matrix components with target ana� lytes. In addition, matrix�matched calibrators and deuterated internal standards should also be used.
Another problem that LC-MS and LC-MS/ MS methods may present is the formation of adducts by combination with Na + , K + or N�4 + introduced by the solvent in the chamber. These adducts produce ions of mass�to�charge ratios higher than expected by factors of 23, 40 or 18 Da. In addition, these adducts do contain mul� tiple salt ions and are capable of forming bridges between ions of differing masses, which will complicate mass spectra interpretation [164, 165] . Unlike GC-MS, the development of search� able libraries for LC-MS and LC-MS/MS is still a problem, since fragmentation and spectra differ between instruments. �owever, despite interinstrument reproducibility, these spectra do have many similar features [166, 167] .
Recently, two research groups have been creat� ing homemade libraries, allowing the identifica� tion of therapeutic agents and drugs of abuse, by means of the collision�induced�dissociation (CID) approach [168] [169] [170] [171] [172] . Briefly, the ions are accelerated and a high number of collisions are produced with gaseous solvent molecules, leading to analyte dissociation. These fragments allow the confirmation of the compound's identity, and it is possible to design a library for each instrument.
Liquid chromatography-MS presents a num� ber of advantages over GC-MS, especially for the quantitation of more polar, termolabile or low�dosed drugs [144] , avoiding the complicated and laborious derivatization procedures usually necessary in GC ana lysis [173, 174] . Furthermore, these needed derivatization steps may differ for different compound classes according to their chemical structure. Indeed, for example, amphet� amines are often derivatized by acetylation, while opiates originate better signals using silylating agents. This will pose several difficulties in the development of multi�analyte methods, which is desirable in oral fluid ana lysis, as stated earlier.
As discussed previously, nano�LC systems represent a valid approach to overcome ion�sup� pression phenomena, since the amount of sol� vent present in the chamber is reduced, achieving lower limits of detection. In fact, Tomkins et al. reported a chip�based nanoelectrospray MS/MS method that could detect 0.49 ng of cotinine (metabolite of nicotine) in 1 ml of oral fluid [175] . The amount of specimen extract on the chip was 10 µl, providing a detection limit of 4.9 pg on the column. Accuracy and precision results were not LC-ESI-MS-TOF 1.07 ng/ml; 2 ng/ml for MDA; 0.71 ng/ml; 2 ng/ml for MDMA; 0.22-0.37 ng/ ml; 2 ng/ml for other compounds [61] MOR, COD, MAM, acetylcodeine and heroin 0.5 ml Intercept ® Methanol and ammonium acetate EXSIL BDS C8 Mobile phase A: 5% methanol in ammonium acetate 4 mM; mobile phase B: propan-2-ol 1% and formic acid 0.05% in methanol LC-ESI-MS-MS 1 ng/ml; 2 ng/ml for MAM, COD and acetylcodeine; 2 ng/ ml; 6 ng/ml for MOR; 6 ng/ml; 10 ng/ml for heroin [65] THC 0. for MDMA, 0.5 ng/ml; 1 ng/ml for MDA and EPH, 0.2 ng/ml; 0.5 ng/ml for MA, 0.5 ng/ml; 0.5 ng/ml for AP [77] MOR, MAM, COD, buprenorphine, methadone, HPLC with fluorescence detection 2 ng/ml; 10 ng/ml for all compounds [55] COC, BE and COET LC-ESI-MS-TOF 1 ng/ml; 10 ng/ml for all compounds [79] R-and S-methadone LC-ESI-MS 0.10 ng/ml; 5 ng/ml for R-and S-methadone; 0.25 ng/ml; 0.5 ng/ml for R-and S-EDDP [183] AP EMIT and LC-APCI-MS/MS 10 ng/ml for EMIT; 3.9 ng/ml; 13.1 ng/ml for oxazepam, 2.4 ng/ml; 8.1 ng/ml for temazepam, 2.3 ng/ml; 7.6 ng/ ml for nordazepam, 0.7 ng/ml; 2.3 ng/ml for midazolam, 0.3 ng/ml; 1.1 ng/ml for OH-midazolam, 0.3 ng/ml; 1.2 ng/ml for alprazolam, 0.2 ng/ml; 0.5 ng/ml for OH-alprazolam, 0.8 ng/ml; 2.7 ng/ml for OHethylflurazepam, 0.3 ng/ml; 1.2 ng/ml for lorazepam, 0.4 ng/ml; 1.3 ng/ml for lormetazepam, 2.1 ng/ml; 6.9 ng/ml for diazepam, 3.0 ng/ml; 10.0 ng/ml for zolpidem, 3.9 ng/ml; 13.0 ng/ ml for zopiclone, 0.0 ng/ml; 0.1 ng/ml for nitazepam [81] Midazolam, 1'-hydroxymidazolam and 4-hydroxymidazolam [190] Metronidazole and spiramycin I LC-ESI-MS/ MS 50 ng/ml for metronidazole; 15 ng/ml for spiramycin [90] Docetaxel, paclitaxel, 6-OH-paclitaxel and p-3'-OH-paclitaxel 0. 25 reported and, despite the small injection volume, occasional specimens had reduced signal, which was possibly due to ion suppression from oral fluid interferences. An approach to improve laboratory through� put and analyze a large number of analytes in a single run is to use ultraperformance liquid chromatography (UPLC) systems, which employ particle diameters as small as 1.5 µm and oper� ating pressures higher than 5000 psi. �owever, despite having several applications in the field of toxicology [164, [176] [177] [178] [179] , this technology has scarce application in oral fluid ana lysis [180] .
�owever, identification of unknowns is a hard task for LC-MS/MS instruments. This can be overcome by the use of time�of�flight (TOF) mass spectrometers, which allow accurate mass measurement. This determination is performed by measuring flight time after acceleration in a vacuum tube by high voltage, and ion paths in the order of 2 m with flight times of 5-100 µs allow rapid and accurate time measurements. This results in short ana lysis times, accurate mass measurements and large dynamic ranges.
The elemental formula can be determined from molecular mass, and interpretation is usu� ally unambiguous. Indeed, there are reports on the reduction of choices to two or three unknown substances using a library of 7640 compounds without considering LC retention times [147] . The application of TOF technology to oral fluid specimens is reported in studies such as those by Clauwaert et al. [79] for the determination of cocaine and metabolites in oral fluid, by Mortier et al. [61] for amphetamines, opiates and cocaine, and by Quintela et al. [69] for cannabinoids.
Liquid chromatography-MS/MS�based methods are the state�of�the�art in analyzing oral fluid samples, due to the high sensitivity and specificity provided, and there has been a considerable number of published papers on the topic, which are summarized in Table 2 .
Conclusion & future perspective
Oral fluid testing is becoming more and more important in analytical toxicology, namely in the fields of clinical and forensic toxicology. Indeed, sample collection is performed easily in a nonin� vasive matter and, if necessary, under close super� vision. This brings several advantages, including the cooperation of the person being analyzed and the difficulty in sample substitution or adultera� tion. One of the most prominent issues concern� One of the most prominent issues concern� ing the use of this biological specimen is that it can provide the ability to assess situations of driving under the influence of drugs, to which the development of easy�to�use on�site collection devices has contributed. Indeed, this type of instrument can provide a result within minutes of sample collection, which should be confirmed afterwards in laboratorial ana lysis.
This laboratorial ana lysis is only possible due to the huge improvement in analytical technolo� gies seen over the last two decades, including both screening and confirmatory techniques. None of these techniques should be regarded as the 'unique solution to all the problems'. On the contrary, these techniques complement each other and, currently, their use is common in most laboratories.
Still, analytical instruments are becoming more sensitive and specific, which enables both drug detection and quantitation in very low amounts, and analyses where concentrations are expected to be low, as occurs in oral fluid. While the main analytical problems are adequately dealt with, more investigation is needed, namely on the establishment of saliva�to�plasma ratios of several drugs, aiding result interpretation.
In general, biological matrices are complex, as is oral fluid. Therefore, despite the high selectiv� ity presented by analytical instruments, it is gen� erally mandatory that the samples are thoroughly cleaned�up before chromatographic ana lysis can be performed. In addition, ion�suppression/ enhancement effects should be comprehensively studied, since the precision and accuracy of the method may be compromised. This may be a problem in terms of detection limits, which rep� resent a very important issue when analyzing oral fluid, since, in most situations, the amount of available sample is small.
No one knows what the future holds for oral fluid ana lysis, but it is expected that analytical equipment will become more sensitive and min� iaturization will be a reality. In fact, the concept of a system with small specimen size, low detec� tion limits, multiple drug testing platforms and high throughput is promising. 
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Executive summary
Physiology & mechanisms of drug incorporation n Drug incorporation can occur by passive diffusion through the membrane, active processes against a concentration gradient, filtration through pores in the membrane and pinocytosis. n Drug incorporation is pH dependent. n Little D 9 -tetrahydrocannabinol (THC; main constituent of cannabis) is secreted into saliva and, therefore, the majority of THC found in oral fluid originates from a deposit after smoking. n The parent drug is the main compound detected in oral fluid, rather than its metabolites. n Passive contamination is possible by exposure to an environment where drugs are being consumed by others.
Collection procedures & devices
n The collection of saliva after stimulating its production can alter drug concentrations in this specimen. n Saliva can be easily obtained without stimulation by spitting or the draining method. n The recovery of drugs from the collection devices is concentration dependent and varies according to the analyte and collection device. n Drug stability in the matrix should be studied, since it can affect the utility of the collection process.
Applicability of oral fluid analysis
n Oral fluid can be used to assess an individual's exposure to virtually every class of compounds, but drugs of abuse are by far the most detected substances. n Analytical applications of oral fluid include therapeutic drug monitoring, pharmacokinetic studies, workplace medicine and detection of illicit drugs in driving situations.
Analytical technologies
n On-site collection devices -On-site portable devices can be used for the assessment of drug-impaired driving situations. The advantages of on-site testing are rapid turnaround times, reduced costs and the fact that the test can be carried out virtually anywhere. -Several studies have been conducted in the EU and USA to assess the utility of oral fluid analysis in driving situations.
n Immunoassays -Immunoassays are extremely useful, since they allow the saving of time and money, which would be wasted in more expensive confirmatory methods (usually mass spectrometric-based techniques), while most of the samples would be negative. -Immunoassays are in general aimed at the parent compound. -The presumptive positive samples must be confirmed by more specific techniques, namely mass spectrometric methods.
-Their poor sensitivity for low-dose compounds, such as flunitrazepam, might still be a problem.
n Gas chromatography-mass spectrometry (GC-MS) -GC-MS has been the most utilized technique for the confirmation of a number of organic compounds, mainly due to the availability of spectral libraries for drugs and metabolites. -GC-MS is currently available in most laboratories, and this is still the main technique for confirmation and quantitation of drugs and their metabolites in biological specimens, including the so-called 'alternative' specimens, such as oral fluid, hair and sweat. -The limits obtained when GC-MS-based techniques are used present a limitation in terms of oral fluid, mainly due to little sample availability for analysis. -One possibility to overcome this problem is the use of tandem mass spectrometry.
n Liquid chromatography-mass spectrometry (LC-MS) -LC-MS permits the analysis of nonvolatile, labile and/or high-molecular-weight compounds.
-Electrospray ionization (ESI) and atmospheric pressure chemical ionization (APCI) have become the most widespread ionization techniques. -LC-MS is highly susceptible to matrix effects (ion suppression or enhancement), and these must be assessed during method development and validation. -Tandem mass spectrometry improves the detection limits.
-The use of time-of-flight mass spectrometers, which allow accurate mass measurement, allows the identification of unknowns. 
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